Login
Home
Charts
Search
Watchlist
Products

GKB Ophthalmics Ltd

GKB·BSE
67.60-1.54%Tue, 22 Sept '26

GKB Ophthalmics Ltd

GKB
BSE
67.60
-1.54%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
34Cr
Close
Close Price
68.30
Industry
Industry
Personal Care
PE
Price To Earnings
12.13
PS
Price To Sales
0.23
Revenue
Revenue
150Cr
Rev Gr TTM
Revenue Growth TTM
29.95%
PAT Gr TTM
PAT Growth TTM
170.50%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
202422262626313230573033
Growth YoY
Revenue Growth YoY%
9.925.88.016.928.17.343.924.215.4120.1-4.02.3
Expenses
ExpensesCr
212522252627343227552730
Operating Profit
Operating ProfitCr
00010-1-313233
OPM
OPM%
-1.5-2.00.14.0-0.2-3.5-9.22.510.12.910.48.2
Other Income
Other IncomeCr
0010000001-11
Interest Expense
Interest ExpenseCr
001111111111
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-1-1-10-1-2-4-12112
Tax
TaxCr
000000000000
PAT
PATCr
-1-1-10-1-2-4-12112
Growth YoY
PAT Growth YoY%
-208.3-35.958.0-107.31.7-32.6-364.0-1,500.0260.0137.2127.1389.1
NPM
NPM%
-5.7-6.0-4.1-0.1-4.4-7.4-13.3-2.06.11.33.85.6
EPS
EPS
-2.3-2.5-1.8-0.5-2.4-4.0-7.0-2.03.20.10.42.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
202422262626313230573033
Growth YoY
Revenue Growth YoY%
9.925.88.016.928.17.343.924.215.4120.1-4.02.3
Expenses
ExpensesCr
212522252627343227552730
Operating Profit
Operating ProfitCr
00010-1-313233
OPM
OPM%
-1.5-2.00.14.0-0.2-3.5-9.22.510.12.910.48.2
Other Income
Other IncomeCr
0010000001-11
Interest Expense
Interest ExpenseCr
001111111111
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-1-1-10-1-2-4-12112
Tax
TaxCr
000000000000
PAT
PATCr
-1-1-10-1-2-4-12112
Growth YoY
PAT Growth YoY%
-208.3-35.958.0-107.31.7-32.6-364.0-1,500.0260.0137.2127.1389.1
NPM
NPM%
-5.7-6.0-4.1-0.1-4.4-7.4-13.3-2.06.11.33.85.6
EPS
EPS
-2.3-2.5-1.8-0.5-2.4-4.0-7.0-2.03.20.10.42.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
447678575957717588109149150
Growth
Revenue Growth%
24.474.71.9-26.62.4-2.824.76.416.923.536.829.9
Expenses
ExpensesCr
467577565655667288112140139
Operating Profit
Operating ProfitCr
-221122541-3911
OPM
OPM%
-4.02.41.72.03.64.16.84.90.7-2.55.87.0
Other Income
Other IncomeCr
1340212111201
Interest Expense
Interest ExpenseCr
211112122232
Depreciation
DepreciationCr
112443333333
PBT
PBTCr
83-1-2-2-120-3-736
Tax
TaxCr
400000000000
PAT
PATCr
43-1-1-2-120-3-736
Growth
PAT Growth%
400.1-34.5-137.5-13.7-66.659.3359.7-94.0-2,664.1-137.4142.8170.5
NPM
NPM%
9.03.4-1.3-1.9-3.1-1.32.70.1-3.4-6.52.03.7
EPS
EPS
9.56.2-2.3-2.6-3.6-1.82.5-0.3-5.6-14.02.45.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
447678575957717588109149150
Growth
Revenue Growth%
24.474.71.9-26.62.4-2.824.76.416.923.536.829.9
Expenses
ExpensesCr
467577565655667288112140139
Operating Profit
Operating ProfitCr
-221122541-3911
OPM
OPM%
-4.02.41.72.03.64.16.84.90.7-2.55.87.0
Other Income
Other IncomeCr
1340212111201
Interest Expense
Interest ExpenseCr
211112122232
Depreciation
DepreciationCr
112443333333
PBT
PBTCr
83-1-2-2-120-3-736
Tax
TaxCr
400000000000
PAT
PATCr
43-1-1-2-120-3-736
Growth
PAT Growth%
400.1-34.5-137.5-13.7-66.659.3359.7-94.0-2,664.1-137.4142.8170.5
NPM
NPM%
9.03.4-1.3-1.9-3.1-1.32.70.1-3.4-6.52.03.7
EPS
EPS
9.56.2-2.3-2.6-3.6-1.82.5-0.3-5.6-14.02.45.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44455555555
Reserves
ReservesCr
4143414754585858554748
Current Liabilities
Current LiabilitiesCr
2333363741383941466271
Non Current Liabilities
Non Current LiabilitiesCr
22212244466
Total Liabilities
Total LiabilitiesCr
69828393102107110112115125132
Current Assets
Current AssetsCr
51636464737476848799108
Non Current Assets
Non Current AssetsCr
1819193029333529272624
Total Assets
Total AssetsCr
69828393102107110112115125132
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44455555555
Reserves
ReservesCr
4143414754585858554748
Current Liabilities
Current LiabilitiesCr
2333363741383941466271
Non Current Liabilities
Non Current LiabilitiesCr
22212244466
Total Liabilities
Total LiabilitiesCr
69828393102107110112115125132
Current Assets
Current AssetsCr
51636464737476848799108
Non Current Assets
Non Current AssetsCr
1819193029333529272624
Total Assets
Total AssetsCr
69828393102107110112115125132

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-11-3-34375-34-3-4
Investing Cash Flow
Investing Cash FlowCr
1541-10-4-17-41-239
Financing Cash Flow
Financing Cash FlowCr
-3-111343-2-2-21-6
Net Cash Flow
Net Cash FlowCr
0-1074-70-4100
Free Cash Flow
Free Cash FlowCr
-13-9-5-6010-22-6-5
CFO To PAT
CFO To PAT%
-289.6-131.6274.4-354.8-177.5-916.0260.8-2,385.2-141.548.5-125.8
CFO To EBITDA
CFO To EBITDA%
656.5-186.1-198.6342.5152.8296.4104.5-75.3728.8123.3-44.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-11-3-34375-34-3-4
Investing Cash Flow
Investing Cash FlowCr
1541-10-4-17-41-239
Financing Cash Flow
Financing Cash FlowCr
-3-111343-2-2-21-6
Net Cash Flow
Net Cash FlowCr
0-1074-70-4100
Free Cash Flow
Free Cash FlowCr
-13-9-5-6010-22-6-5
CFO To PAT
CFO To PAT%
-289.6-131.6274.4-354.8-177.5-916.0260.8-2,385.2-141.548.5-125.8
CFO To EBITDA
CFO To EBITDA%
656.5-186.1-198.6342.5152.8296.4104.5-75.3728.8123.3-44.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
275548432241465544302634
Price To Earnings
Price To Earnings
6.921.436.423.612.1
Price To Sales
Price To Sales
0.60.70.60.80.40.70.70.70.50.30.20.2
Price To Book
Price To Book
0.61.21.10.80.40.70.70.90.70.60.50.7
EV To EBITDA
EV To EBITDA
-17.632.641.441.010.715.68.614.065.0-11.23.93.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.319.919.826.726.726.029.028.325.827.325.825.8
OPM
OPM%
-4.02.41.72.03.64.16.84.90.7-2.55.87.0
NPM
NPM%
9.03.4-1.3-1.9-3.1-1.32.70.1-3.4-6.52.03.7
ROCE
ROCE%
18.37.80.3-0.1-0.51.54.62.5-1.2-6.59.09.0
ROE
ROE%
8.85.5-2.2-2.1-3.1-1.23.10.2-5.0-13.65.75.7
ROA
ROA%
5.73.2-1.2-1.2-1.8-0.71.80.1-2.6-5.72.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
275548432241465544302634
Price To Earnings
Price To Earnings
6.921.436.423.612.1
Price To Sales
Price To Sales
0.60.70.60.80.40.70.70.70.50.30.20.2
Price To Book
Price To Book
0.61.21.10.80.40.70.70.90.70.60.50.7
EV To EBITDA
EV To EBITDA
-17.632.641.441.010.715.68.614.065.0-11.23.93.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.319.919.826.726.726.029.028.325.827.325.825.8
OPM
OPM%
-4.02.41.72.03.64.16.84.90.7-2.55.87.0
NPM
NPM%
9.03.4-1.3-1.9-3.1-1.32.70.1-3.4-6.52.03.7
ROCE
ROCE%
18.37.80.3-0.1-0.51.54.62.5-1.2-6.59.09.0
ROE
ROE%
8.85.5-2.2-2.1-3.1-1.23.10.2-5.0-13.65.75.7
ROA
ROA%
5.73.2-1.2-1.2-1.8-0.71.80.1-2.6-5.72.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — GKB Ophthalmics Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/r85m5pvad50c55jbiqkolgtb.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/72abf2ql6zp79zm9j2i3yo7i.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/fswc15hofs413hrnr1lt87ed.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/298n8p8l7s8upoi9ky1itquo.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ir23js90dzlmujkeud1ckzf2.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/veb3cogrglathmcpkkpxd75w.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/yvzx6lhi0iboc1hafm7tsqdc.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/1rvj06mo9qrr5qpbiz60vzyu.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/blielert33m2gv65nf65y17j.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/15n5rrwd0mp3bsct50w25rnp.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/quksclrvov2fnteyjq1jm1k4.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/3vsoyznrfyl7i9n0gqi93yi8.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/029kkosyckktjuauqsik7f7t.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/27a7e758h2vnkpo7gbu1g0pk.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/kqto5vc18n8mkh86znxg1ndc.pdf